Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin-copolymer vials.

Sixtine GilliotHéloïse HenryNatacha CartaStéphanie GenayChristine BarthélémyBertrand DécaudinPascal Odou

Published in: European journal of hospital pharmacy : science and practice (2021)

Our results argue in favour of adopting the compounding of ready-to-use 10 mg/mL dobutamine solutions in COC vials in centralised intravenous additive services.

Keyphrases

healthcare
primary care
high dose
mental health
room temperature
hyaluronic acid
quality control
drug delivery
ionic liquid
health insurance